NYSE American: AEON

AEON Biopharma, Inc. (AEON)

AEON Biopharma, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker AEON. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
AEON
Exchange
NYSE American
SEC CIK
1837607
Official filings
SEC EDGAR

Research AEON

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is AEON Biopharma, Inc.'s stock ticker?

AEON Biopharma, Inc. trades under the ticker symbol AEON on NYSE American. Its SEC Central Index Key (CIK) is 1837607.

Where can I read AEON Biopharma, Inc.'s SEC filings?

The AEON SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports AEON Biopharma, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze AEON's financial statements?

The AEON Financials page shows AEON Biopharma, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does AEON compare with its peers and the market?

The AEON Peer Comparison page lines AEON Biopharma, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.